Abbott Laboratories Declares $0.63 Quarterly Dividend, Extends 54-Year Raise Streak

Abbott Laboratories (NYSE: ABT), a global healthcare technology company, declared a quarterly dividend of $0.63 per share on Feb. 20, 2026. The payment marks the company's 409th consecutive quarterly dividend. Read more dividend announcements.

The dividend is payable May 15, 2026, to shareholders of record at the close of business on April 15, 2026.

Abbott has increased its dividend payout for 54 consecutive years, maintaining its membership in the S&P 500 Dividend Aristocrats Index. The index tracks companies that have annually increased their dividend for at least 25 consecutive years.

First-Quarter Business Performance

Abbott reported 13.2 percent sales growth in its Medical Devices segment on a reported basis and 8.5 percent on a comparable basis in the first quarter. The growth was driven by double-digit increases in Electrophysiology, Heart Failure and Rhythm Management.

In Diabetes Care, sales of continuous glucose monitors grew 14.2 percent on a reported basis and 7.6 percent on a comparable basis.

Financial Guidance

The company projects full-year 2026 comparable sales growth of 6.5 percent to 7.5 percent. Abbott expects full-year 2026 adjusted diluted earnings per share of $5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact Sciences.

For the second quarter of 2026, Abbott projects adjusted diluted earnings per share of $1.25 to $1.31.

Abbott operates a portfolio spanning diagnostics, medical devices, nutritionals and branded generic medicines. The company employs 122,000 people serving customers in more than 160 countries.